Glycine-MCPA - instructions for use, dose, side effects, contraindications

Glycine is a regulator of metabolism, normalizes and activates the processes of protective inhibition in the central nervous system, reduces psychoemotional stress, increases mental performance.

Glycine is glycine- and GABA-ergic, alpha₁-adrenoblocking, antioxidant, antitoxic action; regulates the activity of glutamate (NMDA) receptors, due to which the drug is able to:

- reduce psychoemotional tension, aggressiveness, conflict, improve social adaptation;

- to improve mood;

- to facilitate falling asleep and normalize sleep;

- increase mental performance;

- to reduce vegetative-vascular disorders (including in the climacteric period);

- reduce the toxic effect of alcohol and other drugs that depress the function of the central nervous system.

Pharmacokinetics:

Easily penetrates into most biological fluids and body tissues, incl. in the brain; metabolized to water and carbon dioxide, its accumulation in tissues does not occur.

Indications:

- Reduced mental performance, psychoemotional stress in stressful situations (including exams, conflict situations);

- Deviant forms of behavior of children and adolescents;

- Various functional and organic diseases of the nervous system, accompanied by increased excitability, emotional instability, decreased mental performance and sleep disturbances (vegetative dystonia syndrome, neuroses, neurosis-like conditions, neuroinfections and craniocerebral trauma, perinatal and other forms of encephalopathies (including alcoholic genesis));

- cerebral infarction;

- in narcology - as a drug that increases mental performance and reduces psychoemotional stress during remission in cases of encephalopathy, organic lesions of the central and peripheral nervous system.

Contraindications:Individual hypersensitivity to the components of the drug.

Dosing and Administration:

Glycine-MCPA is applied sublingually (under the tongue) or buccal to 100 mg (in tablets or as a powder after grinding 1 tablet).

In children under 3 years of age, it is used in the form of a powder dissolved in water.

Children, adolescents and adults with psychoemotional stress, memory loss, attention, mental performance, mental retardation, with deviant forms of behavior, Glycine-MCPA is prescribed 1 tablet 3 times a day for 14-30 days.

With functional and organic lesions of the nervous system, accompanied by increased excitability, emotional lability and sleep disturbances:

- children under three years appoint 0.5 tablets (50 mg), powdered and dissolved in a teaspoon of water, 2-3 times a day for 7-14 days, then 0.5 tablets (50 mg),powdered and dissolved in a teaspoon of water, once a day for 7-10 days. The daily dose is 100-150 mg, the exchange dose is 2-2.6 g;

- children over 3 years and adults appoint 1 tablet 2-3 times a day, the course of treatment 7-14 days. The course of treatment can be increased to 30 days, if necessary, the course is repeated after 30 days.

When sleep disorders, Glycine-MCPA is prescribed 20 minutes before bedtime or just before bedtime, 0.5-1 tablets (depending on the age).

With a cerebral infarction within 3-6 hours of the development of a heart attack, 10 Glycine-MCPP tablets are given transbuccally or sublingually with 1 teaspoon of water, then for 1-5 days at 1 g / day, then for the next 30 days by 1- 2 tablet 3 times a day.

In narcology, Glycine-MCPA is administered 1 tablet 2-3 times a day for 14-30 days. If necessary, the courses are repeated 4-6 times a year.

Side effects:

Allergic reactions are possible.

Overdose:

Data on overdose are absent.

Interaction:

It reduces the severity of side effects of antipsychotics (antipsychotics), anxiolytics, antidepressants, hypnotics and anticonvulsants.

Effect on the ability to drive transp. cf. and fur:

There are no data on the impact on the ability to drive and other mechanisms.

Form release / dosage:Tablets are sublingual, 100 mg.

Packaging:

For 10 tablets in a contour mesh package, 5 circuit packs per pack of cardboard along with instructions for medical use.

Storage conditions:

AT dry, protected from light, out of the reach of children, at temperatures not exceeding 30 ° C.

Shelf life:

3 years.

Do not use after the expiry date printed on the package.

Terms of leave from pharmacies:Without recipe

Registration number:P N003742 / 01

Date of registration:02.10.2009 / 11.10.2011

Expiration Date:Unlimited

The owner of the registration certificate:MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC MOSHIMFARM PREPARATES them. N.А.Semashko, OJSC Russia

Manufacturer: & nbsp

MOSHIMFARM PREPARATES them. NA Semashko OJSC Russia

Representation: & nbspMOSHIMFARM PREPARATES them. NA Semashko OJSC MOSHIMFARM PREPARATES them. NA Semashko OJSC Russia

Information update date: & nbsp01.05.2017

Illustrated instructions

Instructions

Glycine-MCPP (Glycine)